Table 3.
Probiotics supplementation compared to control during neonatal period | |||||
---|---|---|---|---|---|
Patient or population: neonates (Mmost of the included studies had preterm and low birth weight neonates) | |||||
Setting: low and middle income countries | |||||
Intervention: probiotics/synbiotics | |||||
Comparison: control | |||||
Outcomes | No. of participants (studies) Follow up | Certainty of the evidence (GRADE) | Relative effect (95% CI) | Anticipated absolute effects* (95% CI) | |
Risk with control | Risk difference with probiotics (intervention) | ||||
All‐cause mortality | 10904 (25 RCTs) | ⊕⊕⊕⊕ HIGHa, b, c, d | RR, 0.80 (0.66–0.96) | Study population | |
47 per 1000 | 9 fewer per 1000 (15 fewer to 1 fewer) | ||||
Neonatal sepsis | 8918 (21 RCTs) | ⊕⊕⊕⊕ HIGHa, d, e | RR, 0.78 (0.70–0.86) | Study population | |
205 per 1000 | 45 fewer per 1000 (62 fewer to 29 fewer) | ||||
Necrotizing enterocolitis | 55574 (29 RCTs) | ⊕⊕⊕⊕ HIGHa, d, f | RR, 0.46 (0.35–0.61) | Study population | |
101 per 1000 | 55 fewer per 1000 (66 fewer to 41 fewer) | ||||
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). | |||||
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio; | |||||
GRADE Working Group grades of evidence | |||||
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect | |||||
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different | |||||
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect | |||||
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect |
Even though three (Dongol Singh et al., 2017; Fernández‐Carrocera et al., 2013; Kaban et al., 2019) of the included studies in the analysis had high ROB related to randomizations, the exclusion of these studies did not have much effect on the magnitude of the summary estimate or its statistical significance.
I 2 was 0%.
All‐cause mortality is an objective outcome and there were no concerns about the indirect measurement of the outcome.
The confidence interval of the summary estimate did not include 1.
I 2 was 23% and the p. value for heterogeneity was 0.16.
The I 2 was 24%.